You're absolutely right that the economic burden to the individual living with diabetes can be really very significant, depending on their form of treatment. Diabetes Canada has statistics to suggest that more than 30% of those living with diabetes report having been unable to follow their doctor's prescribed treatment plan due to the cost of the devices, the supplies and the medications required.
Obviously, the consultations on an approach to national pharmacare are of great interest to us and to the people we represent. Diabetes Canada believes strongly that every Canadian needs access to the right medications at the right time. Access also needs to be provided at the minimum possible cost to the individual. I think there are significant gaps right now in access to medications, devices and supplies, all of which are currently getting in the way of the people who live with diabetes from achieving their best health longer term. I think those must be addressed. They represent a significant part of our recommendations under Diabetes 360°, in consequence.